Real-world effectiveness and safety of insulin glargine 100 U/mL plus lixisenatide in adults with type 2 diabetes: An international, multicentre, 12-month, prospective observational study.

Autor: Malik RA; Research Division, Weill Cornell Medicine-Qatar, Qatar Foundation, Education City, Qatar., Hwu CM; Section of Endocrinology and Metabolism, Taipei Veterans General Hospital, Taipei, Taiwan., Jammah AA; Endocrinology and DM Division, Department of Medicine, King Saud University, King Saud University Medical City, Riyadh, Saudi Arabia., Arteaga-Díaz JM; Division of Endocrinology, Department of Internal Medicine, School of Medicine, Universidad Nacional de Colombia, Bogotá, Colombia., Djaballah K; Sanofi, Paris, France., Pilorget V; Sanofi, Paris, France., Alvarez A; Sanofi, Madrid, Spain., Vera C; Ividata Life Sciences, Levallois-Perret, France., Vikulova O; Endocrinology Research Centre, Moscow, Russian Federation.

Publikováno v: Diabetes, obesity & metabolism [Diabetes Obes Metab] 2024 Jul; Vol. 26 (7), pp. 2811-2819. Date of Electronic Publication: 2024 Apr 18.

IDF21-0416 Mortality risk factors due to COVID-19 in diabetic patients according to the nationwide diabetes register analysis

Autor: Shestakova, M., Vikulova, O., Ajnetdinova, A., Dedov, I., Mokrysheva, N.

Publikováno v: In Diabetes Research and Clinical Practice April 2022 186 Supplement 1

Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings

Autor: Magliano, DJ, Chen, L, Islam, RM, Carstensen, B, Gregg, EW, Pavkov, ME, Andes, LJ, Balicer, R, Baviera, M, Boersma-van Dam, E, Booth, GL, Chan, JCN, Chua, YX, Fosse-Edorh, S, Fuentes, S, Gulseth, HL, Gurevicius, R, Ha, KH, Hird, TR, Jermendy, G, Khalangot, MD, Kim, DJ, Kiss, Z, Kravchenko, VI, Leventer-Roberts, M, Lin, CY, Luk, AOY, Mata-Cases, M, Mauricio, D, Nichols, GA, Nielen, MM, Pang, D, Paul, SK, Pelletier, C, Pildava, S, Porath, A, Read, SH, Roncaglioni, MC, Ruiz, PLD, Shestakova, M, Vikulova, O, Wang, KL, Wild, SH, Yekutiel, N, Shaw, JE

Publikováno v: Lancet Diabetes & Endocrinology
r-IIB SANT PAU. Repositorio Institucional de Producción Científica del Instituto de Investigación Biomédica Sant Pau
Instituto de Salud Carlos III (ISCIII)

Background Diabetes prevalence is increasing in most places in the world, but prevalence is affected by both risk of developing diabetes and survival of those with diabetes. Diabetes incidence is a better metric to understand the trends in population

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=RECOLECTA___::dac8a471985c8fd6f6ad47d70e07fbcd
https://iibsantpau.fundanetsuite.com/Publicaciones/ProdCientif/PublicacionFrw.aspx?id=5694

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings.

Autor: Magliano DJ; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia. Electronic address: dianna.magliano@baker.edu.au., Chen L; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia., Islam RM; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Carstensen B; Clinical Epidemiology, Steno Diabetes Center Copenhagen, Gentofte, Denmark., Gregg EW; Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK., Pavkov ME; Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA., Andes LJ; Division of Diabetes Translation, Centers for Disease Control and Prevention, Atlanta, GA, USA., Balicer R; Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel., Baviera M; Laboratory of Cardiovascular Prevention, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy., Boersma-van Dam E; Department of General Practice, Netherlands Institute for Health Services Research, Utrecht, Netherlands., Booth GL; Department of Medicine, University of Toronto, Toronto, ON, Canada., Chan JCN; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Chua YX; Epidemiology and Disease Control Division, Public Health Group, Ministry of Health, Singapore., Fosse-Edorh S; Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France., Fuentes S; Department of Non-Communicable Diseases and Trauma, Santé Publique France, Saint-Maurice, France., Gulseth HL; Department for Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway., Gurevicius R; Center of Health Information, Institute of Hygiene, Vilnius, Lithuania; Faculty of Public Governance and Business, Mykolas Romeris University, Vilnius, Lithuania., Ha KH; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea., Hird TR; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia., Jermendy G; 3rd Medical Department, Bajcsy-Zsilinszky Hospital, Budapest, Hungary., Khalangot MD; Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences, Kyiv, Ukraine; Endocrinology Department, Shupyk National Medical Academy of Postgraduate Education, Kyiv, Ukraine., Kim DJ; Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, South Korea., Kiss Z; 2nd Department of Medicine and Nephrological Center, Medical Faculty, University of Pécs, Pécs, Hungary., Kravchenko VI; Komisarenko Institute of Endocrinology and Metabolism, National Academy of Medical Sciences, Kyiv, Ukraine., Leventer-Roberts M; Clalit Research Institute, Clalit Health Services, Tel Aviv, Israel; Department of Pediatrics and Department of Environmental Medicine and Public Health, Icahn School of Medicine at Mount Sinai, New York, NY, USA., Lin CY; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan., Luk AOY; Department of Medicine and Therapeutics, Chinese University of Hong Kong, Hong Kong Special Administrative Region, China., Mata-Cases M; CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; DAP-Cat Group, Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain., Mauricio D; CIBER of Diabetes and Associated Metabolic Diseases, Instituto de Salud Carlos III, Barcelona, Spain; DAP-Cat Group, Institut Català de la Salut, Unitat de Suport a la Recerca Barcelona Ciutat, Institut Universitari d'Investigació en Atenció Primària Jordi Gol, Barcelona, Spain; Department of Endocrinology and Nutrition, Hospital de la Santa Creu i Sant Pau, Autonomous University of Barcelona, Barcelona, Spain., Nichols GA; Science Programs Department, Kaiser Permanente Center for Health Research, Portland, OR, USA., Nielen MM; Department of General Practice, Netherlands Institute for Health Services Research, Utrecht, Netherlands., Pang D; Epidemiology and Disease Control Division, Public Health Group, Ministry of Health, Singapore., Paul SK; Melbourne EpiCentre, University of Melbourne, Melbourne, VIC, Australia., Pelletier C; Centre for Surveillance and Applied Research, Public Health Agency of Canada, Ottawa, ON, Canada., Pildava S; Research and Health Statistics Department, Centre for Disease Prevention and Control, Riga, Latvia., Porath A; Research Institute, Maccabi Healthcare Services, Tel Aviv, Israel; Faculty of Health, Ben Gurion University, Beer-Sheva, Israel., Read SH; Usher Institute, University of Edinburgh, Edinburgh, UK., Roncaglioni MC; Laboratory of Cardiovascular Prevention, Mario Negri Institute for Pharmacological Research IRCCS, Milan, Italy., Lopez-Doriga Ruiz P; Department for Chronic Diseases and Ageing, Norwegian Institute of Public Health, Oslo, Norway; Department of Endocrinology, Morbid Obesity and Preventive Medicine, Oslo University Hospital, Oslo, Norway., Shestakova M; Diabetes Institute, Endocrinology Research Center, Moscow, Russia., Vikulova O; Diabetes Institute, Endocrinology Research Center, Moscow, Russia., Wang KL; General Clinical Research Center, Taipei Veterans General Hospital, Taipei, Taiwan., Wild SH; Usher Institute, University of Edinburgh, Edinburgh, UK., Yekutiel N; Research Institute, Maccabi Healthcare Services, Tel Aviv, Israel., Shaw JE; Department of Diabetes and Population Health, Baker Heart and Diabetes Institute, Melbourne, VIC, Australia; School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia; School of Life Sciences, Latrobe University, Bundoora, VIC, Australia.

Publikováno v: The lancet. Diabetes & endocrinology [Lancet Diabetes Endocrinol] 2021 Apr; Vol. 9 (4), pp. 203-211. Date of Electronic Publication: 2021 Feb 23.